The Black Lung Benefits Improvement Act of 2025 streamlines the process for coal miners and their families to obtain benefits for black lung disease. Key provisions include a program to cover attorneys' fees and medical expenses for qualifying claims, clearer eligibility standards based on medical evidence like CT scans and biopsies, and ensuring benefits adjust for inflation to maintain their value. The bill also requires a strategy to reduce case backlogs and improves the financial security of the trust fund that pays benefits. This legislation directly affects coal miners diagnosed with black lung disease, their surviving spouses, and dependent family members who rely on these benefits for financial support.
The Patients Deserve Price Tags Act requires hospitals, clinical diagnostic laboratories, imaging services providers, and ambulatory surgical centers to publicly disclose detailed pricing information for healthcare services in machine-readable formats. This includes standard charges, discounted cash prices, payer-specific negotiated rates, and other relevant pricing data that consumers can easily access and compare. The law applies to all facilities that provide services to Medicare beneficiaries, with implementation dates starting in 2026 for hospitals and 2027 for other providers. Non-compliant facilities face daily civil monetary penalties ranging from $300 to $10,000 per day, depending on facility size and duration of non-compliance.
This bill would allow states to waive certain Affordable Care Act requirements for health insurance plans, with federal funds instead deposited into "Trump health freedom accounts" for eligible individuals. It makes changes to health savings accounts to increase flexibility, creates new employer health reimbursement arrangements, and prohibits federal funding for gender transition procedures and most abortions (with exceptions for rape, incest, or to save a mother's life). The bill also includes provisions to expand short-term health insurance plans and create a reinsurance program for off-exchange plans. These changes would affect individuals purchasing health insurance, employers offering health benefits, and states that choose to participate in the waiver program.
This bill would require health insurance plans that cover obstetrical services to also cover a broad range of fertility treatments, including in vitro fertilization, artificial insemination, embryo preservation, and fertility medications. It mandates coverage regardless of whether a person has been diagnosed with infertility, with cost-sharing (deductibles, coinsurance) limited to the same level as other medical services. The law would apply to employer-sponsored health plans, individual insurance, Medicare, Medicaid, TRICARE, and VA benefits, with implementation deadlines ranging from January 1, 2026 for Medicare to January 1, 2027 for notice requirements. The bill also prohibits plans from discouraging fertility treatment or limiting providers who offer it, while ensuring coverage is provided without requiring individuals to undergo treatment.
This resolution (HRES 245) formally recognizes Sjögren’s disease as a serious systemic autoimmune condition affecting approximately 4 million Americans, primarily women aged 45-55. It encourages federal health agencies to expand research, improve diagnosis through provider education, and track patient numbers, while designating April 2025 as "Sjögren’s Awareness Month." The bill directly affects patients managing chronic symptoms like dryness, fatigue, and organ complications, as well as healthcare providers who diagnose and treat the disease. As a symbolic resolution, it does not create new laws or funding but aims to increase national awareness and research focus.
This bill requires the Medicare program to audit prior authorization rules for high-cost items and drugs by 2027, identifying those needing excessive paperwork steps. By 2028, it mandates standardized prior authorization rules across all Medicare Advantage plans for these specific items and drugs. The law exempts providers in certain risk-based care models (like accountable care organizations) from these standardized requirements. It directly affects Medicare Advantage enrollees and plans by simplifying paperwork for certain treatments and medications. The bill aims to reduce administrative burdens for providers and patients without changing coverage decisions.
This bill (S 3688, RURAL Rate Act) increases Medicare reimbursement rates for healthcare providers in certain rural areas. It requires the Medicare program to set a minimum floor of 1.67 for practice expense and work geographic payment indices after January 1, 2026, if the standard calculation would produce a lower rate. This directly affects doctors and clinics in designated rural locations that currently receive lower Medicare payments due to geographic pricing. The change ensures these providers receive at least 1.67 times the standard rate for services, aiming to address historical underpayment. The policy applies to Medicare Part B payments for services furnished in qualifying rural areas starting in 2026.
This bill reinstates $200 transfer and manufacturing taxes on most firearms (replacing reduced rates from prior law) and maintains a $5 tax for "other weapons," affecting firearm manufacturers and dealers. It also adds $1.7 billion to the Medicare Part A trust fund for fiscal year 2026 to support hospital insurance costs. The tax changes apply 90 days after enactment, while the Medicare funding is available until expended. The bill directly impacts firearms industry costs and provides dedicated funding for Medicare's hospital insurance program.
S 3346, the Freedom to Heal Act of 2025, creates a new registration process for physicians to administer Schedule I investigational drugs under the federal Right to Try program. It directly affects physicians who wish to treat eligible patients with these experimental drugs by requiring them to apply to the Attorney General with specific documentation, including manufacturer agreements and proof of state compliance. Key provisions include a 45-day approval timeline for applications, limits on drug quantities based on submitted requests, and requirements for secure storage and record-keeping. The bill mandates the Attorney General to issue interim rules within 240 days to implement these registration standards, focusing on preventing diversion while enabling patient access.
This bill permanently extends the enhanced premium tax credit for Affordable Care Act marketplace insurance plans, directly affecting millions of lower-income households (earning 150%-400% of the federal poverty level) who purchase coverage through state or federal marketplaces. It establishes a sliding-scale percentage system where the tax credit reduces monthly premiums based on income, starting at 0% for households earning up to 150% of poverty and increasing to 8.5% for those earning 300%-400% of poverty. The bill replaces temporary provisions with permanent rules, ensuring consistent cost-sharing support for eligible buyers. The changes apply to tax years beginning after December 31, 2025.
